Announcement PDF Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.s Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and made be made public. Introduced 30/09/2001 Name of entity: Emyria Limited ABN: 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director: Stewart Washer Date of last notice: 16 November 2020 Part 1 - Change of director’s relevant interests in securities Note: In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family Superannuation Fund> (Dr Washer is a trustee and beneficiary of the Note: Provide details of the circumstances giving rise to the relevant interest. superannuation fund) Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family Trust> (Dr Washer is a trustee and beneficiary of the Trust) Mal Washer Nominees Pty Ltd <Mal Washer Family A/C> (Dr Washer is a trustee and beneficiary of the trust) Date of change 23 February 2023 No. of securities held prior to change Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family Superannuation Fund> (Dr Washer is a trustee and beneficiary of the 1,325,599 Ordinary Shares Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family Trust> 28,400,000 Ordinary Shares 1,500,000 Unlisted Options Mal Washer Nominees Pty Ltd <Mal Washer Family A/C> 19,600,000 Ordinary Shares superannuation fund) (Dr Washer is a trustee and beneficiary of the Trust) exercisable at $0.45 expiring 13 June 2023 (Dr Washer is a trustee and beneficiary of the trust) + See chapter 19 for defined terms Appendix 3Y pg. 1 Appendix 3Y Change of Director’s Interest Notice Class changed Ordinary Shares Unlisted Options Number acquired 333,333 Ordinary Shares 166,667 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Number disposed - Value/Consideration $0.18 per Ordinary Share $0.00 per Ordinary Option Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family Superannuation Fund> (Dr Washer is a trustee and beneficiary of the 1,325,599 Ordinary Shares Dr Stewart James Washer & Dr Patrizia Derna Washer <The Washer Family Trust> 28,400,000 Ordinary Shares 1,500,000 Unlisted Options Mal Washer Nominees Pty Ltd <Mal Washer Family A/C> 19,933,333 Ordinary Shares 166,667 Unlisted Options Unlisted Options exercisable at $0.35 on or before 22 November 2025 Nature of change Issue of placement securities following shareholder approval at General Meeting superannuation fund) (Dr Washer is a trustee and beneficiary of the Trust) (Dr Washer is a trustee and beneficiary of the trust) Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back exercisable at $0.45 expiring 13 June 2023 Part 2 - Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change N/A Interest acquired N/A Interest disposed N/A Value/Consideration N/A Note: Details are only required for a contract in relation to which the interest has changed Note: if consideration is non-cash, provide details and an estimated valuation + See chapter 19 for defined terms Appendix 3Y pg. 2 Appendix 3Y Change of Director’s Interest Notice Interest after changes N/A Part 3 – Closed Period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? Yes If so, was prior written clearance provided to allow the trade to proceed during this period? Yes If prior written clearance was provided, on what date was this provided? 20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended. + See chapter 19 for defined terms Appendix 3Y pg. 3 Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Emyria Limited ACN 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Dr Michael Winlo Date of last notice 28 November 2022 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Michael Gordon Winlo <The Winlo A/C> (Michael Winlo is trustee and a beneficiary of this trust) Date of change 23 February 2023 No. of securities held prior to change Michael Gordon Winlo 60,000 Ordinary Shares Michael Gordon Winlo <The Winlo A/C> 3,500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 4,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 3,000,000 Unlisted Options exercisable at $0.296 on or before 23 November 2026 Class Ordinary Shares Unlisted Options Number acquired 222,222 Ordinary Shares 111,111 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Number disposed - Note: Provide details of the circumstances giving rise to the relevant interest. Value/Consideration $0.18 Per Ordinary Share $0.00 per attaching Option No. of securities held after change Michael Gordon Winlo 282,222 Ordinary Shares 111,111 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Michael Gordon Winlo <The Winlo A/C> 3,500,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 4,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 3,000,000 Unlisted Options exercisable at $0.296 on or before 23 November 2026 Nature of change Issue of placement securities following shareholder approval at General Meeting Note: If consideration is non-cash, provide details and estimated valuation Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Part 2 – Change of director’s interests in contracts – N/A Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest Name of registered holder (if issued securities) N/A N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the securities or Yes contracts detailed above traded during a +closed period where prior written clearance was required? If so, was prior written clearance provided to Yes allow the trade to proceed during this period? If prior written clearance was provided, on 20/02/2023 what date was this provided? On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended. Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.s Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and made be made public. Introduced 30/09/2001 Name of entity: Emyria Limited ABN: 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director: Alistair Vickery Date of last notice: 16 November 2020 Part 1 - Change of director’s relevant interests in securities Note: In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust. In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct and Indirect Nature of indirect interest (including registered holder) Netwealth Investments Limited <Super Services A/C> Note: Provide details of the circumstances giving rise to the relevant interest. Dr Vickery is a member of a managed superannuation fund Cherylyn Vickery <Vickery Family Trust> Dr Vickery is a beneficiary of this trust> Date of change 23 February 2023 No. of securities held prior to change Alistair Vickery Netwealth Investments Limited <Super Services A/C> 128,000 Ordinary Shares Alistair Vickery 2,000,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 Cherylyn Vickery <Vickery Family Trust> 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 Class changed Ordinary Shares Unlisted Options Number acquired 138,889 Ordinary shares 69,444 Unlisted Options exercisable at $0.35 on or before 22 November 2025 + See chapter 19 for defined terms Appendix 3Y pg. 1 Appendix 3Y Change of Director’s Interest Notice Number disposed - Value/Consideration $0.18 per Ordinary Share $0.00 per attaching Option Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change Netwealth Investments Limited <Super Services A/C> 128,000 Ordinary Shares Alistair Vickery 138,889 Ordinary Shares 2,000,000 Unlisted Options exercisable at $0.45 on or before 13 June 2023 69,444 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Cherylyn Vickery <Vickery Family Trust> 2,000,000 Unlisted Options exercisable at $0.114 on or before 13 November 2024 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Issue of placement securities following shareholder approval at General Meeting Part 2 - Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest N/A Name of registered holder (if issued securities) N/A Date of change N/A No. and class of securities to which interest related prior to change N/A Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after changes N/A Note: Details are only required for a contract in relation to which the interest has changed Note: if consideration is non-cash, provide details and an estimated valuation Part 3 – Closed Period Were the interests in the securities or contracts detailed above traded during a +closed period where prior written clearance was required? + See chapter 19 for defined terms Yes Appendix 3Y pg. 2 Appendix 3Y Change of Director’s Interest Notice If so, was prior written clearance provided to allow the trade to proceed during this period? Yes If prior written clearance was provided, on what date was this provided? 20/02/2023 On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended. + See chapter 19 for defined terms Appendix 3Y pg. 3 Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Emyria Limited ACN 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Mr Matthew Callahan Date of last notice 16 November 2020 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Indirect Nature of indirect interest (including registered holder) Mercator Shipwrights Pty Ltd <Mercator Trust> (Mr Callahan is a Note: Provide details of the circumstances giving rise to the relevant interest. beneficiary of this Trust) Shenasaby Pty Ltd < Shenasaby Trust> (Mr Callahan is a beneficiary of this trust) Date of change 23 February 2023 No. of securities held prior to change Mercator Shipwrights Pty Ltd <Mercator Trust> 19,600,000 Ordinary Shares Shenasaby Pty Ltd < Shenasaby Trust> 1,500,000 Unlisted options exercisable at $0.114 on or before 13 November 2024 Class Ordinary Shares Unlisted Options Number acquired 55,556 Ordinary Shares 27,778 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Number disposed - Value/Consideration $0.18 per Ordinary Share $0.00 per attaching Option Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change Mercator Shipwrights Pty Ltd <Mercator Trust> 19,655,556 Ordinary Shares 27,778 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Shenasaby Pty Ltd < Shenasaby Trust> 1,500,000 Unlisted options exercisable at $0.114 on or before 13 November 2024 Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Issue of placement securities following shareholder approval at General Meeting Part 2 – Change of director’s interests in contracts – N/A Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest Name of registered holder (if issued securities) N/A N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the securities or Yes contracts detailed above traded during a +closed period where prior written clearance was required? If so, was prior written clearance Yes provided to allow the trade to proceed during this period? If prior written clearance was 20/02/2023 provided, on what date was this On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would provided? participate in a placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended. Appendix 3Y Rule 3.19A.2 Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced 30/09/01 Amended 01/01/11 Name of entity Emyria Limited ACN 625 085 734 We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act. Name of Director Karen Smith Date of last notice 7 December 2021 Part 1 - Change of director’s relevant interests in securities In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part. Direct or indirect interest Direct Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. Date of change 23 February 2023 No. of securities held prior to change 550,000 Ordinary Shares 1,500,000 Unlisted options exercisable at $0.268 expiring on 22/2/2024 Class Ordinary Shares Unlisted Options Number acquired 83,333 Ordinary Shares 41,667 Unlisted Options Unlisted Options exercisable at $0.35 on or before 22 November 2025 Number disposed - Value/Consideration $0.18 per Ordinary Share $0.00 per attaching Option Note: If consideration is non-cash, provide details and estimated valuation No. of securities held after change 633,333 Ordinary Shares 1,500,000 Unlisted options exercisable at $0.268 expiring on 22/2/2024 41,667 Unlisted Options exercisable at $0.35 on or before 22 November 2025 Nature of change Issue of placement securities following shareholder approval at General Meeting Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back Part 2 – Change of director’s interests in contracts Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part. Detail of contract N/A Nature of interest Name of registered holder (if issued securities) N/A N/A Date of change N/A No. and class of securities to which N/A interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired N/A Interest disposed N/A Value/Consideration N/A Interest after change N/A Note: If consideration is non-cash, provide details and an estimated valuation Part 3 – +Closed period Were the interests in the Yes securities or contracts detailed above traded during a +closed period where prior written clearance was required? If so, was prior written Yes clearance provided to allow the trade to proceed during this period? If prior written clearance 20/02/2023 was provided, on what On 31 October 2022 the Company announced that, subject to shareholder approval, certain Directors would participate in a date was this provided? placement at $0.18 per share with 1 attaching option exercisable at $0.35 for each 2 shares issued. Shareholder approval was received on 25 January 2023 for Director participation with the issue of securities to be within 1 month of approval. As Director participation and shareholder approval was received prior to the current blackout period coming into force Directors resolved to proceed with the issue within the blackout period with participants agreeing not to deal in the securities until the blackout period has ended.